(Q21142645)

17 August 2022

8

Myron Cohen

Myron

Cohen

1 reference

17 August 2022

7

Joseph Eron

Joseph

Eron

1 reference

17 August 2022

1

Nancie M Archin

Nancie M

Archin

1 reference

17 August 2022

4

Ann

Wiegand

Ann Wiegand

1 reference

17 August 2022

6

John M

Coffin

John M Coffin

1 reference

17 August 2022

Manzoor Cheema

2

Manzoor

Cheema

1 reference

17 August 2022

Daniel Parker

series ordinal

3

author given names

Daniel

author last names

Parker

1 reference

17 August 2022

Ronald J Bosch

series ordinal

5

author given names

Ronald J

author last names

Bosch

1 reference

Creative Commons Attribution 4.0 International

17 August 2022

language of work or name

English

0 references

publication date

2010

0 references

published in

PLOS One

0 references

volume

5

0 references

issue

2

0 references

page(s)

e9390

0 references

copyright license

start time

23 February 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826423

Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826423

Depletion of latent HIV-1 infection in vivo: a proof-of-concept study

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826423

HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826423

No evidence for decay of the latent reservoir in HIV-1-infected patients receiving intensive enfuvirtide-containing antiretroviral therapy

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826423

Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826423

Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826423

Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826423

Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826423

A limited group of class I histone deacetylases acts to repress human immunodeficiency virus type 1 expression

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826423

The challenge of finding a cure for HIV infection

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826423

Pharmaceutical approaches to eradication of persistent HIV infection

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826423

Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826423

New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826423

Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826423

Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826423

Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826423

Stability of the latent reservoir for HIV-1 in patients receiving valproic acid

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826423

Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826423

10.1371/JOURNAL.PONE.0009390

29 November 2018

Identifiers

DOI

1 reference

ADS bibcode

2010PLoSO...5.9390A

0 references

1 reference

1 reference

1 reference